Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,069 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical development of immuno-oncology in China.
Wu DW, Huang HY, Tang Y, Zhao Y, Yang ZM, Wang J, Wang SH, Yu Y, Fang Y, Fang H, Bai Y, Sun C, Fan Q, Yu AQ, Wang HL, Du CX, Chen K, Huang MD, Zhang Y, Li N, Xu BH, Sun Y, He J. Wu DW, et al. Among authors: fang h, fang y. Lancet Oncol. 2020 Aug;21(8):1013-1016. doi: 10.1016/S1470-2045(20)30329-6. Lancet Oncol. 2020. PMID: 32758460 No abstract available.
[Acceptance and Related Causes of Clinical Trials among Cancer Patients in China].
Huang H, Fan Q, Fang H, Wu D, Wang S, Bai Y, Yu A, Wang H, Sun C, Yu Y, Fang Y, Yang S, Shi J, He R, Li N. Huang H, et al. Among authors: fang h, fang y. Zhongguo Fei Ai Za Zhi. 2020 Jan 20;23(1):41-49. doi: 10.3779/j.issn.1009-3419.2020.01.07. Zhongguo Fei Ai Za Zhi. 2020. PMID: 31948537 Free PMC article. Chinese.
Availability of anticancer biosimilars in 40 countries.
Huang HY, Wu DW, Ma F, Liu ZL, Shi JF, Chen X, Wang SH, Fang H, Bai Y, Yu Y, Fang Y, Sun C, Fan Q, Wu Y, Fan RH, Zhou CY, He BX, Dai M, Li N, Xu BH, Sun Y, He J. Huang HY, et al. Among authors: fang h, fang y. Lancet Oncol. 2020 Feb;21(2):197-201. doi: 10.1016/S1470-2045(19)30860-5. Lancet Oncol. 2020. PMID: 32007192 No abstract available.
Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies.
Wang S, Chen R, Tang Y, Yu Y, Fang Y, Huang H, Wu D, Fang H, Bai Y, Sun C, Yu A, Fan Q, Gu D, Yi X, Li N. Wang S, et al. Among authors: fang h, fang y. Front Oncol. 2020 Apr 21;10:536. doi: 10.3389/fonc.2020.00536. eCollection 2020. Front Oncol. 2020. PMID: 32373528 Free PMC article.
The Landscape of Cell and Gene Therapies for Solid Tumors.
Wang S, Sun F, Huang H, Chen K, Li QJ, Zhang L, Wang E, Wang C, Zhang H, Yuan AQ, Chen B, Deng T, Liu Y, Sun J, Liu D, Yu Y, Fang Y, Jiang N, Wu D, Fang H, Bai Y, Xing S, Ni Y, Fan Q, Yu A, Sun C, Tang Y, Li N, Xu B, He J. Wang S, et al. Among authors: fang h, fang y. Cancer Cell. 2021 Jan 11;39(1):7-8. doi: 10.1016/j.ccell.2020.12.005. Cancer Cell. 2021. PMID: 33434513 Free article. No abstract available.
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review.
Huang HY, Liu CC, Yu Y, Wang L, Wu DW, Guo LW, Wang SH, Fang H, Bai Y, Fang Y, Fan Q, Sun C, Wu Y, Shi JF, Ma F, Tang Y, Dai M, Li N. Huang HY, et al. Among authors: fang h, fang y. Front Pharmacol. 2020 Nov 12;11:572569. doi: 10.3389/fphar.2020.572569. eCollection 2020. Front Pharmacol. 2020. PMID: 33536905 Free PMC article. Review.
16,069 results
You have reached the last available page of results. Please see the User Guide for more information.